New EU legislation for limiting animal testing without hindering scientific research

14 July 2010

The use of animals in scientific experiments could soon be reduced by new legislation, approved by the European Commission's Agriculture Committee this week, which strives to strike the right balance between improving animal welfare and assisting research against diseases.

If endorsed by the full Parliament and Council, the new legislation would require competent national authorities to assess the animal welfare implications of each experiment done, with a view to promoting alternative testing methods and reducing the levels of pain inflicted on animals.

The new legislation would also tighten up rules on the use of primates in scientific experiments, inter alia by classifying tests according to severity and specifying the inspections necessary to ensure compliance.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical